TRENDS AND CONSIDERATIONS IN GLOBAL CARDIOVASCULAR DRUG DEVELOPMENT

Regulatory Trends: Safety Requirements, Endpoint Definition, Expanding Trial Size and Cost Regulatory trends driven by increasing safety requirements and more rigorous definitions of study endpoints are leading to larger and longer clinical studies. Following the safety recall of Vioxx and several other wi